About Saitama City hospital
さいたま市立病院は埼玉県さいたま市緑区三室にある医療機関。埼玉県災害拠点病院となっている。老朽化にともない2017年から病棟の全面的な建て替えに着手し、2019年12月29日に新しい病棟で開院、2020年1月6日から外来診療を開始した。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Saitama City hospital
During the past decade, Saitama City hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
1998-12-01
Terminated
36
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
1999-03-01
2001-11-01
Completed
4
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
1998-11-01
Unknown status
102
Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
2000-07-01
2005-10-01
Completed
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
2000-10-01
Unknown status
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
2000-07-01
2004-02-01
Completed
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
2001-01-01
Unknown status
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama City hospital"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Saitama City hospital
According to Clinical.Site data, the most researched conditions in "Saitama City hospital" are
"Low Back Pain" (2 trials), "Chronic Pain" (1 trials), "Growth Hormone Deficiency" (1 trials), "Hypophosphatasia" (1 trials) and "Non Muscular Invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Saitama City hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saitama City hospital
Most popular intervention types in "Saitama City hospital" are "Biological" (5 trials), "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tanezumab 5 mg" (2 trials), "CG0070" (1 trials), "CP-690,550" (1 trials), "Celecoxib" (1 trials) and "Genotropin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saitama City hospital
The vast majority of trials in "Saitama City hospital" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Saitama City hospital
Currently, there are NaN active trials in "Saitama City hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Saitama City hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saitama City hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".